Waters Corp
Close on Nov 20, 2026Market cap $43.27BP/E 109.8Yield –
Waters Advanced Diagnostics Division Revenue by Quarter
Advanced Diagnostics Division (ADx) Revenue (Comparable Basis) ($M)
Waters Advanced Diagnostics Division Revenue: $575M in Q3 2026, up 798.4% from a year earlier.
Where the Q3 2026 figure comes from
“Advanced Diagnostics Division (ADx) 575 64 797%”
Source: Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗
Combines Waters' Clinical Business Unit (LC-MS IVD diagnostics) with the acquired BD Diagnostic Solutions business (Microbiology, BACTEC, Kiestra, Phoenix, BD MAX, BD COR, Onclarity, Veritor).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Advanced Diagnostics Division (ADx) Revenue (Comparable Basis) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 575 | +798.4% | Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q2 2026 | Jun 30, 2026 | 521 | +740.3% | Q2 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q1 2026 | Mar 31, 2026 | 349 | +558.5% | Q1 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q3 2025 | Sep 30, 2025 | 64 | – | Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q2 2025 | Jun 30, 2025 | 62 | – | Q2 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
| Q1 2025 | Mar 31, 2025 | 53 | – | Q1 2026 Form 8-K (Item 2.02 Earnings Release) ↗ |
Breakdown
What makes up advanced Diagnostics Division Revenue
Cite this data
StockData. (2026). Waters Advanced Diagnostics Division Revenue ($M), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Waters SEC filings and investor materials. https://stockdatahq.com/stocks/wat/kpis/adx-total-comp
See every metric in the Waters KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?